STERLINBIO

Members of the Exchange are hereby informed that the admission to dealings in securities of the company Sterling Biotech Limited shall be withdrawn (delisted) w.e.f. March 03, 2023 pursuant to Hon ble National Company Law Tribunal (NCLT) order dated November 11, 2022.

Sterling Biotech Limited has informed the Exchange about Liquidation process

Sterling Biotech Limited has informed the Exchange about Liquidation

Sterling Biotech Limited has informed the Exchange about Corporate Insolvency Resolution Process

Please find attached herewith Audited Financial Statement for the financial year 2020-21 of Sterling Biotech Limited along with Auditors Report.

Sterling Biotech Limited has informed the Exchange about Corporate Insolvency Resolution Process

Non Applicability Certificate Corporate Governance June 2021

Please find attached herewith Audited Financial Statement for the financial year 2019-20 of Sterling Biotech Limited along with Auditors Report.

Please find attached herewith Audited Financial Statement for the financial year 2018-19 of Sterling Biotech Limited duly signed by Mr. Sundaresh Bhat (Erstwhile Resolution Professional) dated 18.02.2021 along with Auditors' Report.

Intimation of Public Announcement for seeking claim (Intimation under Regulation 30 of SEBI (LODR),2015)

INTIMATION OF LIQUIDATION PROCESS AS PER REGULATION 30 OF SEBI(LODR) 2015

Sterling Biotech Limited has informed the Exchange regarding 'Confirmation Certificate in the matter of Regulation 74(5) of SEBI(Depositories and Participants) Regulations, 2018 for quarter ended September 2020'.

Sterling Biotech Limited has informed the Exchange regarding 'Order Of Hon ble Supreme Court, New Delhi, dated 17th December 2019 - Dairy No. 44707 of 2019 In Civil Appeal No. 9430/2019 (Arising out of impugned final judgment and order dated 18-11-2019 in IA No. 2787/2019 passed by the National Company Law Apellate Tribunal).'.

Sterling Biotech Limited has informed the Exchange regarding 'Order of National Company Law Appellate Tribunal, New Delhi - I.A No. 2787 of 2019 IN Company Appeal (AT) (Insolvency) No. 612 of 2019'.

Sterling Biotech Limited has informed the Exchange that Intimation of Initial disclosure of the Company identified as a Large Corporate referencing SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018.

Sterling Biotech Limited has informed the Exchange regarding intimation as per the requirement of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Sterling Biotech Limited has informed the Exchange that Please find attached herewith the clarification for non compliance of Regulation 33 of SEBI LODR

Sterling Biotech Limited has informed the Exchange regarding 'Confirmation Certificate in the matter of Regulation 74(5) of SEBI(Depositories and Participants) Regulations, 2018 for quarter ended JUNE, 2019'.

The Exchange has sought clarification from Sterling Biotech Limited with respect to recent news item captioned ED attaches assets worth over Rs 9,000 cr in Sterling Biotech PMLA case. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Sterling Biotech Limited has submitted their response.

The Exchange has sought clarification from Sterling Biotech Limited with respect to news item captioned ��ED attaches assets worth over Rs 9,000 cr in Sterling Biotech PMLA case��. The response from the Company is awaited.

Sterling Biotech Limited has informed the Exchange regarding 'Intimation as per the requirement of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015'.

The Exchange had sought clarification from Sterling Biotech Limited with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI -2. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. -3. Board meeting notice not submitted. The response of the Company is enclosed.

Sterling Biotech Limited has informed the Exchange regarding 'Intimation regarding Public Announcement made under Regulation 12 of Insolvency and Bankruptcy Board of India (Liquidation Process) Regulations, 2016 as per the requirement of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding 'Intimation of Liquidation Commencement under the provisions of the Insolvency & Bankruptcy Code, 2016 and appointment of Liquidator as per the requirement of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015'.

The Exchange has sought clarification from the Company with respect to news item captioned- titled "RBI found irregularities in guarantees to Sterling Bio". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company was aware of any information that has not been announced to the Exch

Sterling Biotech Limited has informed the Exchange regarding Change in Auditors of the company.

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding 'Update on the result of the voting through electronic means in terms of Regulation 26(4) of the Insolvency and Bankruptcy Board of India (Insolvency Resolution Process for Corporate Persons) Regulations, 2016'.

Sterling Biotech Limited has informed the Exchange regarding 'Update on the result of the voting through electronic means in terms of Regulation 26(4) of the Insolvency and Bankruptcy Board of India (Insolvency Resolution Process for Corporate Persons) Regulations, 2016'.

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding 'Update on the result of the voting through electronic means in terms of Regulation 26(4) of the Insolvency and Bankruptcy Board of India (Insolvency Resolution Process for Corporate Persons) Regulations, 2016'.

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on February 11, 2019.

Sterling Biotech Limited has submitted to the Exchange, the financial results for the period ended December 31, 2018.

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding Outcome of Meeting of Resolution Professional held on February 01, 2019.

Sterling Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2018.

Sterling Biotech Limited has submitted to the Exchange, the financial results for the period ended June 30, 2018.

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding Committee Meeting to be held on January 14, 2019.

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.